| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ras oncogene activation and occupational exposures in acute myeloid leukemia.
|
J Natl Cancer Inst
|
1992
|
2.54
|
|
2
|
Centrifugal enhancement of retroviral mediated gene transfer.
|
J Virol Methods
|
1995
|
1.76
|
|
3
|
Morphologic and cytochemical characteristics of acute promyelocytic leukemia.
|
Am J Hematol
|
1989
|
1.54
|
|
4
|
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia.
|
Blood
|
1996
|
1.49
|
|
5
|
CTLA-4 blockade by a human MAb enhances the capacity of AML-derived DC to induce T-cell responses against AML cells in an autologous culture system.
|
Cytotherapy
|
2006
|
1.41
|
|
6
|
Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells.
|
Blood
|
1996
|
1.29
|
|
7
|
Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia.
|
Blood
|
1994
|
1.22
|
|
8
|
Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
|
J Immunol
|
1985
|
1.09
|
|
9
|
Trisomy 13: a new recurring chromosome abnormality in acute leukemia.
|
Blood
|
1990
|
1.07
|
|
10
|
Cytotoxic activity of gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukemia correlates with the expression of protein kinase Syk.
|
Leukemia
|
2006
|
1.06
|
|
11
|
Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol).
|
J Immunol
|
1984
|
1.05
|
|
12
|
Monoclonal antibodies to novel myeloid antigens reveal human neutrophil heterogeneity.
|
Proc Natl Acad Sci U S A
|
1982
|
1.04
|
|
13
|
Differentiation of a human monocytic cell line by 1,25-dihydroxyvitamin D3 (calcitriol): a morphologic, phenotypic, and functional analysis.
|
Blood
|
1984
|
1.01
|
|
14
|
Heterogeneity of clonogenic cells in acute myeloblastic leukemia.
|
J Clin Invest
|
1985
|
1.00
|
|
15
|
Thrombotic thrombocytopenic purpura: combined treatment with plasmapheresis and antiplatelet agents.
|
Ann Intern Med
|
1980
|
1.00
|
|
16
|
An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia.
|
Blood
|
1997
|
0.98
|
|
17
|
Ovarian recovery after stem cell transplantation.
|
Bone Marrow Transplant
|
2007
|
0.97
|
|
18
|
Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1).
|
Cancer Res
|
1996
|
0.96
|
|
19
|
Gamma interferon induces monocytoid differentiation in the HL-60 cell line.
|
J Clin Invest
|
1984
|
0.94
|
|
20
|
Immune markers in hematologic malignancies.
|
Crit Rev Oncol Hematol
|
1991
|
0.91
|
|
21
|
Optimal use of G-CSF administration after hematopoietic SCT.
|
Bone Marrow Transplant
|
2009
|
0.91
|
|
22
|
Glucocorticoid enhances gamma interferon effects on human monocyte antigen expression and ADCC.
|
Clin Exp Immunol
|
1986
|
0.91
|
|
23
|
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
|
Bone Marrow Transplant
|
2004
|
0.90
|
|
24
|
The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation.
|
Blood
|
1983
|
0.89
|
|
25
|
Monoclonal antibodies to myeloid differentiation antigens: in vivo studies of three patients with acute myelogenous leukemia.
|
Blood
|
1983
|
0.89
|
|
26
|
Toxicity of busulfan and cyclophosphamide (BU/CY2) in patients with hematologic malignancies.
|
Bone Marrow Transplant
|
1996
|
0.89
|
|
27
|
The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells.
|
Blood
|
1985
|
0.89
|
|
28
|
Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia.
|
Leukemia
|
1998
|
0.89
|
|
29
|
Regulation of p21(WAF1) expression during normal myeloid differentiation.
|
Blood
|
1998
|
0.89
|
|
30
|
Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
|
Blood
|
1986
|
0.88
|
|
31
|
Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
|
Am J Hematol
|
1995
|
0.86
|
|
32
|
The expression and modulation of human myeloid-specific antigens during differentiation of the HL-60 cell line.
|
Blood
|
1983
|
0.86
|
|
33
|
Autologous peripheral blood stem cell transplantation and adoptive immunotherapy with activated natural killer cells in the immediate posttransplant period.
|
Clin Cancer Res
|
1995
|
0.85
|
|
34
|
Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: results from the expanded access program.
|
Bone Marrow Transplant
|
2012
|
0.85
|
|
35
|
Restricted usage of VH and V kappa genes by murine monoclonal antibodies against 3-fucosyllactosamine.
|
Eur J Immunol
|
1989
|
0.85
|
|
36
|
Expression of myeloid and major histocompatibility antigens on small cell carcinoma of the lung cell lines analyzed by cytofluorography: modulation by gamma-interferon.
|
Cancer Res
|
1986
|
0.84
|
|
37
|
Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.
|
Int J Breast Cancer
|
2011
|
0.84
|
|
38
|
Induction of differentiation in blast cells and leukemia colony-forming cells from patients with acute myeloid leukemia.
|
Blood
|
1990
|
0.83
|
|
39
|
Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
|
J Immunol
|
1982
|
0.82
|
|
40
|
Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation.
|
Transplantation
|
1995
|
0.82
|
|
41
|
1,25-Dihydroxyvitamin D3 induces a myelomonocytic phenotype with enhanced effector cell function in the HL-60 promyelocytic leukemia cell line.
|
Mol Immunol
|
1985
|
0.82
|
|
42
|
Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
|
Bone Marrow Transplant
|
2001
|
0.81
|
|
43
|
Cytotoxicity of anti-CD64-ricin a chain immunotoxin against human acute myeloid leukemia cells in vitro and in SCID mice.
|
J Hematother Stem Cell Res
|
2001
|
0.81
|
|
44
|
Monoclonal antibodies reactive with human myeloid leukaemia cells.
|
Clin Exp Immunol
|
1982
|
0.81
|
|
45
|
Lysis of small cell carcinoma of the lung (SCCL) cells by cytokine-activated monocytes and natural killer cells in the presence of bispecific immunoconjugates containing a gastrin-releasing peptide (GRP) analog or a GRP antagonist.
|
J Hematother
|
1995
|
0.80
|
|
46
|
Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.
|
Br J Haematol
|
1996
|
0.80
|
|
47
|
Differential effect of 4-hydroperoxycyclophosphamide and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging.
|
Blood
|
1994
|
0.80
|
|
48
|
A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
|
J Immunol
|
1983
|
0.80
|
|
49
|
Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years.
|
Bone Marrow Transplant
|
1997
|
0.80
|
|
50
|
The use of myeloid-specific monoclonal antibodies in the diagnosis of leukemia.
|
Diagn Immunol
|
1983
|
0.80
|
|
51
|
Direct effect of bispecific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells.
|
Leuk Res
|
2001
|
0.79
|
|
52
|
Reversal of graft-versus-host disease with infusion of autologous bone marrow.
|
Cell Transplant
|
1994
|
0.79
|
|
53
|
Transduction of mobilized peripheral blood CD34+ cells with the glucocerebrosidase cDNA.
|
Gene Ther
|
1994
|
0.79
|
|
54
|
Improving the efficiency of PBPC collection by pre-apheresis peripheral blood and mid-apheresis product measurements of CD34 cells.
|
Cytotherapy
|
2004
|
0.79
|
|
55
|
Monoclonal antibodies PMN 6, PMN 29, and PM-81 bind differently to glycolipids containing a sugar sequence occurring in lacto-N-fucopentaose III.
|
Arch Biochem Biophys
|
1984
|
0.79
|
|
56
|
Lysis of small cell carcinoma of the lung tumor cell lines by gamma interferon-activated allogeneic peripheral blood mononuclear cells: abrogation of killing by pretreatment of tumor cells with gamma interferon.
|
Cancer Immunol Immunother
|
1986
|
0.79
|
|
57
|
Transduction of CD34+ enriched cord blood and Gaucher bone marrow cells by a retroviral vector carrying the glucocerebrosidase gene.
|
Gene Ther
|
1994
|
0.78
|
|
58
|
Homologous restriction of complement-mediated cell lysis can be markedly enhanced by blocking decay-accelerating factor.
|
Br J Haematol
|
1995
|
0.78
|
|
59
|
Utility of flow cytometric reticulocyte quantification as a predictor of engraftment in autologous bone marrow transplantation.
|
Am J Hematol
|
1989
|
0.78
|
|
60
|
Idiotypic determinants of monoclonal antibodies that bind to 3-fucosyllactosamine.
|
J Immunol
|
1986
|
0.78
|
|
61
|
Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
|
Clin Cancer Res
|
1995
|
0.77
|
|
62
|
Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation.
|
Bone Marrow Transplant
|
1997
|
0.77
|
|
63
|
Autologous bone marrow transplantation in the treatment of acute myeloid leukemia: the Dartmouth experience and a review of literature.
|
Cancer Invest
|
1990
|
0.77
|
|
64
|
Evaluation of monoclonal antibody-mediated anti-acute myeloid leukemia immunotherapy in a SCID/hu model.
|
Leuk Res
|
1996
|
0.77
|
|
65
|
Elimination of small cell carcinoma of the lung from human bone marrow by monoclonal antibodies and immunomagnetic beads.
|
Cancer Res
|
1990
|
0.77
|
|
66
|
Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells.
|
Br J Haematol
|
1995
|
0.76
|
|
67
|
Comparison of methods for retroviral mediated transfer of glucocerebrosidase gene to CD34+ hematopoietic progenitor cells.
|
Eur J Haematol
|
1998
|
0.76
|
|
68
|
FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia.
|
Bone Marrow Transplant
|
2003
|
0.76
|
|
69
|
Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation.
|
Cytotherapy
|
2000
|
0.76
|
|
70
|
Thy-1 expression on blast cells from adult patients with acute myeloid leukemia.
|
Leuk Res
|
1997
|
0.76
|
|
71
|
A unique population of CD34+ cells in cord blood.
|
Stem Cells
|
1995
|
0.76
|
|
72
|
Xenotransplantation of hematopoietic cells resistant to HIV as a potential treatment for patients with AIDS.
|
Transplant Proc
|
1994
|
0.75
|
|
73
|
Reactivity of anti-CD15 monoclonal antibody PM-81 with breast cancer and elimination of breast cancer cells from human bone marrow by PM-81 and immunomagnetic beads.
|
Cancer Res
|
1991
|
0.75
|
|
74
|
Ex vivo purging and cell expansion.
|
J Hematother Stem Cell Res
|
1999
|
0.75
|
|
75
|
LEAF BURN OF THE POTATO AND ITS RELATION TO THE POTATO LEAFHOPPER.
|
Science
|
1918
|
0.75
|
|
76
|
Purging marrow or peripheral blood stem cells for autografting.
|
Curr Opin Hematol
|
1997
|
0.75
|
|
77
|
Human blood dendritic cell-like B cells isolated by the 5G9 monoclonal antibody reactive with a novel 220-kDa antigen.
|
J Immunol
|
1999
|
0.75
|
|
78
|
Proteins of human brain tissue obtained during surgical procedures.
|
J Neurochem
|
1974
|
0.75
|
|
79
|
The role of natural killer cells in the treatment of chronic myeloid leukemia.
|
J Hematother
|
1995
|
0.75
|
|
80
|
Mitoxantrone in relapsed or refractory acute nonlymphocytic leukemia.
|
Med Pediatr Oncol
|
1988
|
0.75
|
|
81
|
Immunotoxins for ex vivo marrow purging in autologous bone marrow transplantation for acute nonlymphocytic leukemia.
|
Transplantation
|
1988
|
0.75
|
|
82
|
BIOLOGICAL ABSTRACTS.
|
Science
|
1923
|
0.75
|
|
83
|
Methods for Retrovirus-Mediated Gene Transfer to CD34(+) Enriched Cells.
|
Methods Mol Med
|
1997
|
0.75
|
|
84
|
AGRICULTURAL RESEARCH AS A CAREER.
|
Science
|
1923
|
0.75
|
|
85
|
Purging autologous bone marrow with monoclonal antibodies for transplantation in acute myelogenous leukemia.
|
Blood Rev
|
1997
|
0.75
|
|
86
|
Monoclonal antibodies reactive with small cell carcinoma of the lung.
|
J Natl Cancer Inst
|
1984
|
0.75
|
|
87
|
Efficacy of bone marrow purging in AML using monoclonal antibodies and complement.
|
Prog Clin Biol Res
|
1990
|
0.75
|
|
88
|
Sialylated glycolipid antigens on human leukemic cell lines.
|
Exp Hematol
|
1986
|
0.75
|
|
89
|
Continuous infusion of complement by an automated cell processor enhances cytotoxicity of monoclonal antibody sensitized leukemia cells.
|
Bone Marrow Transplant
|
1989
|
0.75
|
|
90
|
BIOLOGICAL ABSTRACTS.
|
Science
|
1924
|
0.75
|
|
91
|
Isodicentric chromosome 18q as sole abnormality in a histologically normal bone marrow from a patient with diffuse large-cell non-Hodgkin's lymphoma.
|
Cancer Genet Cytogenet
|
1991
|
0.75
|
|
92
|
Gamma interferon and 1,25 dihydroxyvitamin D3 cooperate in the induction of monocytoid differentiation but not in the functional activation of the HL-60 promyelocytic leukemia cell line.
|
Exp Hematol
|
1986
|
0.75
|
|
93
|
T-cell depletion improves outcome after autologous stem cell transplant in patients with systemic lupus erythematosus (SLE).
|
Bone Marrow Transplant
|
2005
|
0.75
|
|
94
|
Characterization of a new monoclonal antibody 6G7 that recognizes a unique antigen on myeloid and lymphoid cells.
|
J Hematother Stem Cell Res
|
2001
|
0.75
|
|
95
|
A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
|
J Hematother
|
1996
|
0.75
|
|
96
|
A PUZZLING BUTTERFLY MIGRATION.
|
Science
|
1928
|
0.75
|
|
97
|
Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
|
Bone Marrow Transplant
|
1992
|
0.75
|
|
98
|
Use of capecitabine as first-line therapy in patients with metastatic breast cancer relapsing after high-dose chemotherapy and autologous stem cell support.
|
Clin Oncol (R Coll Radiol)
|
2001
|
0.75
|
|
99
|
A combination of anti-CD15 monoclonal antibody PM-81 and 4-hydroperoxycyclophosphamide augments tumor cytotoxicity while sparing normal progenitor cells.
|
J Hematother
|
1994
|
0.75
|
|
100
|
Cytokine mobilization of peripheral blood stem cells in patients with Gaucher disease with a view to gene therapy.
|
Exp Hematol
|
1995
|
0.75
|
|
101
|
Predictive value of flow cytometric analyses of blast cells in assessing the phenotype of the leukemia colony-forming cell (L-CFC) population in acute myeloid leukemia.
|
Bone Marrow Transplant
|
1992
|
0.75
|
|
102
|
High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer.
|
Am J Clin Oncol
|
1996
|
0.75
|
|
103
|
Caution in the use of 2-iminothiolane (Traut's reagent) as a cross-linking agent for peptides. The formation of N-peptidyl-2-iminothiolanes with bombesin (BN) antagonist (D-Trp(6),Leu(13)-psi[CH(2)NH]-Phe(14))BN(6-14) and D-Trp-Gln-Trp-NH(2).
|
J Pept Res
|
2001
|
0.75
|
|
104
|
Efficient retroviral mediated transfer of the glucocerebrosidase gene in CD34+ enriched umbilical cord blood human hematopoietic progenitors.
|
Exp Hematol
|
1995
|
0.75
|
|
105
|
Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
|
Exp Hematol
|
1988
|
0.75
|
|
106
|
Magnetic affinity colloid (MAC) cell separation of leukemia cells from autologous bone marrow aspirates.
|
Leuk Res
|
1987
|
0.75
|
|
107
|
Brain proteins: qualitative and quantitative changes, synthesis and degradation during fetal development of the rabbit.
|
J Neurochem
|
1972
|
0.75
|
|
108
|
Reversible cyclosporine-induced cortical blindness in allogeneic bone marrow transplant recipients.
|
Bone Marrow Transplant
|
1995
|
0.75
|
|
109
|
A novel monoclonal antibody, SCCL 175, with specificity for small cell neuroendocrine carcinoma of the lung.
|
Cancer Res
|
1988
|
0.75
|
|
110
|
Comments on the Fourth International Conference on Bispecific Antibodies and Cellular Cytotoxicity, Duck Key, Florida, March 1-5, 1995.
|
J Hematother
|
1995
|
0.75
|
|
111
|
Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis.
|
Blood
|
1985
|
0.75
|